BRKR CIK: 1109354

Bruker Corp.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
2.47
FY22:
2.11
FY23:
2.16
FY24:
2.05
FY25:
2.21
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.18
FY22:
1.50
FY23:
2.09
FY24:
3.75
FY25:
4.03
Total assets
Change from FY21 to FY25
billions USD
FY21:
3.65
FY22:
3.61
FY23:
4.25
FY24:
5.81
FY25:
6.24

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.94
FY22:
0.91
FY23:
1.20
FY24:
1.28
FY25:
1.28
(negative)
Change from FY21 to FY25
billions USD
FY21:
1.63
FY22:
1.57
FY23:
1.63
FY24:
2.71
FY25:
2.45
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.07
FY22:
1.11
FY23:
1.38
FY24:
1.78
FY25:
2.46

All amounts in billions USD Data sources:SEC EDGARTwelve Data